Ovid Therapeutics (OVID) Reports Q1 Loss, Tops Revenue Estimates
Yahoo Finance · 2 weeks ago
Open | 3.0400 |
High | 3.0400 |
Low | 2.9900 |
Mkt Cap | 212.83M |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 3.0100 |
52 Wk. Low | 2.5700 |
52 Wk. High | 4.1390 |
Related stocks
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 148k | 124.20% ▲ |
Net Income | -11.69M | - |
Diluted EPS | -0.17 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$0.23 | - |
Q1 2024 | -$0.22 | -$0.17 |
Q4 2023 | -$0.05 | -$0.22 |
S&P 500^GSPC | 5,304.72+36.88 (+0.70%) |
Dow 30^DJI | 39,069.59+4.33 (+0.01%) |
Nasdaq^IXIC | 16,920.79+184.76 (+1.10%) |
Bitcoin USDBTC-USD | 69,024.00-0.03% |
36.19-0.47% | |
150.17+2.94% |